MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

13 May 2026 Evaluate
Revenue showed a marginal decline at Rs. 0.93 millions. For the quarter ended March 2026, as compared to corresponding quarter of last year.The Total Profit for the quarter ended March 2026 of Rs. 0.34 millions grew from Rs.-0.67 millionsThe company reported a degrowth in operating Profit to 1.05 millions from 2.85 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 0.93 0.96 -3.12 3.71 6.11 -39.28 3.71 6.11 -39.28
Other Income 4.73 6.08 -22.20 20.36 20.09 1.34 20.36 20.09 1.34
PBIDT 1.05 2.85 -63.16 6.83 10.58 -35.44 6.83 10.58 -35.44
Interest 0.01 0.01 0.00 0.02 0.01 100.00 0.02 0.01 100.00
PBDT 1.04 2.84 -63.38 6.81 10.57 -35.57 6.81 10.57 -35.57
Depreciation 0.25 0.24 4.17 1.00 0.98 2.04 1.00 0.98 2.04
PBT 0.79 2.60 -69.62 5.81 9.59 -39.42 5.81 9.59 -39.42
TAX 0.45 3.27 -86.24 1.44 6.42 -77.57 1.44 6.42 -77.57
Deferred Tax -0.08 -0.08 0.00 -0.37 2.02 -118.32 -0.37 2.02 -118.32
PAT 0.34 -0.67 -150.75 4.37 3.17 37.85 4.37 3.17 37.85
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 112.90 296.88 -61.97 184.10 173.16 6.32 184.10 173.16 6.32
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..